2014•Annals of the Rheumatic DiseasesRequires access

AB0375 Lengthening of Recommended Dose Range of Anti-TNF Therapy in Patients with Rheumatoid Arthritis and Peripheral Psoriatic Arthritis in Remission

C. Núñez-Cornejo Piquer, I. Chalmeta Verdejo, Clara Molina Almela, I. Martínez Cordellat, CM Feced Olmos, Elena Grau, C. Alcañiz Escandell, L. González Puig, J. Ivorra Cortés, R. Negueroles Albuixech, Marisa Guillén, J.L. Valero Sanz, Jose Andrés Román Ivorra

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Golimumab, Etanercept, Adalimumab, Psoriatic arthritis, Rheumatoid arthritis, Internal medicine, Dosing